LIPOPROTEIN DISORDER
Clinical trials for LIPOPROTEIN DISORDER explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN DISORDER trials appear
Sign up with your email to follow new studies for LIPOPROTEIN DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tackle hidden heart risk: high lp(a)
Disease control OngoingThis phase 2 trial tests an injectable drug called DII235 in 233 adults with high lipoprotein(a), a genetic condition that raises heart disease and stroke risk. Participants have heart disease or type 2 diabetes. The study compares different doses of DII235 against a placebo to s…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New shot aims to slash hidden heart risk in 203 patients
Disease control OngoingThis study tests an experimental drug called HRS-5632 in 203 adults with high levels of lipoprotein(a), a fatty substance that raises the risk of heart attacks and strokes. Participants receive either the drug or a placebo to see if the drug safely lowers this substance. The goal…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Scientists create a 'Lipid Library' to unlock secrets of rare cholesterol conditions
Knowledge-focused OngoingThis study is creating a collection of blood samples and health information from 250 adults with very high or very low cholesterol or related lipid problems. Researchers will analyze these samples to learn more about the genetic and biological causes of these extreme lipid disord…
Matched conditions: LIPOPROTEIN DISORDER
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC